We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Merck, Sysmex Collaborate To Develop And Commercialize Blood-Based RAS Biomarker Test

News   Jun 04, 2014

 
Merck, Sysmex Collaborate To Develop And Commercialize Blood-Based RAS Biomarker Test
 
 
Advertisement
 

RELATED ARTICLES

Trial of Saliva Test for COVID-19 Launched

News

Scientists from the Innovative Genomics Institute (IGI), the same UC Berkeley group that rapidly popped up a state-of-the-art COVID-19 testing laboratory in March, are now trialing a quicker way to obtain patient samples: through saliva.

READ MORE

Portable Diagnostic System Provides On-site COVID-19 Test Results in About an Hour

News

A team of NUS researchers has developed a portable COVID-19 micro-PCR diagnostic system – called Epidax – that enables rapid and accurate on-site screening of infectious diseases and significantly reduces the time required to analyse patient samples.

READ MORE

Atomic Structure of Aβ Protein Assemblies Revealed

News

Researchers have revealed, for the first time, the atomic structure of amyloid-beta (Aβ) protein assemblies.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE